Rapid point-of-care testing for SARS-CoV-2 in a community screening setting shows low sensitivity
Detection Principle
ImmunoAssay-Antibody
Target
IgM, IgG
Testing Method Category
GICA
Testing Method
rapid test (not specified)
Testing Method - Additional Info
The evaluated rapid test is an IgG/IgM–based test for SARS-CoV-2 with a time to result of 20 min. Two drops of blood are needed for the test performance.
Reported Performance
sensitivity: 36.4%; specificity: 88.9%
Sample Size
49 patients
Peer-reviewed
yes
The database contains available information from scientific literature that is being updated periodically. Please note that the provided information (as retrieved from analysed papers) is provided only for devices commercially available with CE-IVD mark. Acknowledgements